SureID, a leader in ePedigree automation demonstrated its PharmaSURE solution for use in drug trials. With PharmaSURE integrated into the trial management system, companies benefit from accelerated trials, regulatory compliance, automated investigator activities, improved patient safety and outcomes.
PharmaSURE is one example of how Microsoft technologies can help meet regulatory requirements and streamline operations. The solution, developed using Microsoft Visual Studio 2005, uses SureID Wave intelligent appliances running Microsoft .NET 2.0 and Windows XP to automate data collection and distribution tasks. Investigator reporting is streamlined using standard RFID tags and PharmaSURE automation software running Windows Server 2003 and Microsoft SQL Server. Patient journals are automatically logged using SureID’s Intelligent Caps, which securely communicate using standard RFID infrastructure. Collected data is securely stored in Microsoft’s SQL database for ease of collaboration and reporting.

“Technology can enable companies to be agile and competitive in a changing business environment,” said Steve Shihadeh, general manager, healthcare and life sciences at Microsoft. “Through its use of Microsoft technologies, SureID is helping its customers to better connect, collaborate and make more informed decisions, which helps them to drive overall business success.”

“Our company helps stakeholders in the pharmaceutical supply chain cost effectively deliver the safest medication to their customers. Our PharmaSURE solution not only improves safety, it improves efficiencies and productivity with real-time visibility and automated execution of processes.” stated Steve Casey, CEO of SureID. “Improving the top and bottom lines while leveraging regulatory expenses is a win-win for everyone.”

The PharmaSURE capabilities that improve drug trials are also used to improve Pharmacy operations and assist in meeting regulatory requirements. The FDA’s recent report lifting the stay on ePedigree regulations and guidance on targeted RFID deployment has increased the need for solutions such as PharmaSURE. “While I was a guest panelist at the FDA workshop in February and in speaking with other stakeholders, it became apparent that the FDA was going to put pressure on the industry” noted Steve Casey. “Although the FDA seldom specifies a technology, the consensus was that RFID would provide tremendous benefit in a phased approach. Our PharmaSURE solution specifically addresses these ePedigree challenges while targeting high-value medications prone to counterfeiting, shrink, and medication errors.